Compositions and methods for treatment of inflammation and hyperkeratotic lesions

Details for Australian Patent Application No. 2009260485 (hide)

Owner Novelix Pharmaceuticals, Inc.

Inventors Jansen, M.D. Burkhard

Agent Madderns

Pub. Number AU-A-2009260485

PCT Pub. Number WO2009/155070

Priority 61/057,696 30.05.08 US

Filing date 28 May 2009

Wipo publication date 23 December 2009

International Classifications

A61K 31/56 (2006.01) - Compounds containing cyclopenta[a]hydrophenanthrene ring systems

A61K 31/575 (2006.01) - substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol

A61P 17/00 (2006.01) Drugs for dermatological disorders

A61P 17/02 (2006.01) Drugs for dermatological disorders

A61P 17/06 (2006.01) Drugs for dermatological disorders

A61P 17/12 (2006.01) Drugs for dermatological disorders

A61P 17/14 (2006.01) Drugs for dermatological disorders

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

23 December 2010 PCT application entered the National Phase

  PCT publication WO2009/155070 Priority application(s): WO2009/155070

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009260486-Motion-controlled views on mobile computing devices

2009260480-Method and apparatus for identifying dietary choices